scholarly journals Dual secured nano-melittin for the safe and effective eradication of cancer cells

2015 ◽  
Vol 3 (1) ◽  
pp. 25-29 ◽  
Author(s):  
Bei Cheng ◽  
Bindu Thapa ◽  
Remant K. C. ◽  
Peisheng Xu

A dual secured nano-melittin system fully retains the wide-spectrum anticancer efficacy of melittin while quenching its lytic activity for the red blood cells.

2016 ◽  
Vol 62 (2) ◽  
pp. 251-256
Author(s):  
Zsuzsanna Erzsébet Papp ◽  
Mária-Adrienne Horváth

AbstractChildhood cancer is a major psycho-social and health problem. International study groups establish complex, efficient, and concrete Cytostatic Protocols for every cancer type. During chemotherapy patients become extremely vulnerable to infections, so it is necessary to complete the treatment with blood substitution, anti-infection medication, growth factors and other complementary products.Materials and Methods: We studied the importance of the wide palette of adjuvant therapy near the intensive cytostatic treatment in the period of March 2014-November 2015 at the hemato-oncology department in Pediatric Clinic of Mures County Hospital.Results: In this period we treated 20 children (9 female, 11 male) aged between 9 months-18 years. We had 15 cases of haemopathies (13 acute leukemia and two lymphomas), and five solid tumors. Packed red blood cells, platelets, and fresh frozen plasma were given in the aplastic period. A patient benefited, on average, a total of 70ml/kg packed red blood cells and 50 U platelets. For infection prophylaxis and treatment every child benefited associated infective medication.Discussions: Packed red blood cells, platelets, and fresh frozen plasma were given to patients with a deficiency in the ability to produce normal blood cells which are temporarily worsened by chemotherapy. Antibiotic and antifungal medications are given to all febrile and neutropenic patients. We use wide spectrum antibiotics in association for preventing sepsis. Growth factors are stimulating the bone marrow to increase leukocyte number. Since introducing additional immunostimulant medication, we observed a significant decrease of infection in the aplastic period.Conclusions: Oncology protocols use only 3-5 cytostatic drugs. Maintaining the patient’s life during the treatment, it is necessary to use a large spectrum of supportive medications.


2020 ◽  
Vol 62 ◽  
pp. 126640
Author(s):  
Benjamaporn Supawat ◽  
Phattharawadi Moungthong ◽  
Chananchida Chanloi ◽  
Natchaporn Jindachai ◽  
Singkome Tima ◽  
...  

2021 ◽  
Vol 14 (4) ◽  
Author(s):  
Benjamaporn Supawat ◽  
Panumas Homnuan ◽  
Natthawan Kanthawong ◽  
Niyada Semrasa ◽  
Singkome Tima ◽  
...  

2017 ◽  
Vol 114 (18) ◽  
pp. 4591-4596 ◽  
Author(s):  
Shabnam A. Faraghat ◽  
Kai F. Hoettges ◽  
Max K. Steinbach ◽  
Daan R. van der Veen ◽  
William J. Brackenbury ◽  
...  

Currently, cell separation occurs almost exclusively by density gradient methods and by fluorescence- and magnetic-activated cell sorting (FACS/MACS). These variously suffer from lack of specificity, high cell loss, use of labels, and high capital/operating cost. We present a dielectrophoresis (DEP)-based cell-separation method, using 3D electrodes on a low-cost disposable chip; one cell type is allowed to pass through the chip whereas the other is retained and subsequently recovered. The method advances usability and throughput of DEP separation by orders of magnitude in throughput, efficiency, purity, recovery (cells arriving in the correct output fraction), cell losses (those which are unaccounted for at the end of the separation), and cost. The system was evaluated using three example separations: live and dead yeast; human cancer cells/red blood cells; and rodent fibroblasts/red blood cells. A single-pass protocol can enrich cells with cell recovery of up to 91.3% at over 300,000 cells per second with >3% cell loss. A two-pass protocol can process 300,000,000 cells in under 30 min, with cell recovery of up to 96.4% and cell losses below 5%, an effective processing rate >160,000 cells per second. A three-step protocol is shown to be effective for removal of 99.1% of RBCs spiked with 1% cancer cells while maintaining a processing rate of ∼170,000 cells per second. Furthermore, the self-contained and low-cost nature of the separator device means that it has potential application in low-contamination applications such as cell therapies, where good manufacturing practice compatibility is of paramount importance.


Biochemistry ◽  
2008 ◽  
Vol 47 (7) ◽  
pp. 2134-2142 ◽  
Author(s):  
Sharada Prasad Yadav ◽  
Aqeel Ahmad ◽  
Brijesh Kumar Pandey ◽  
Richa Verma ◽  
Jimut Kanti Ghosh

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Elisabeth Karsten ◽  
Edmond Breen ◽  
Sharon A. McCracken ◽  
Stephen Clarke ◽  
Benjamin R. Herbert

Sign in / Sign up

Export Citation Format

Share Document